Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives

BioMed Research International
Michael KreuterPaolo Spagnolo

Abstract

Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5-year survival of approximately 20%. The disease primarily occurs in elderly patients. IPF is a highly heterogeneous disorder with a clinical course that varies from prolonged periods of stability to episodes of rapid deterioration. In the last decade, improved understanding of disease mechanisms along with a more precise disease definition has allowed the design and completion of a number of high-quality clinical trials. Yet, until recently, IPF was essentially an untreatable disease. Finally, pirfenidone and nintedanib, two compounds with antifibrotic properties, have consistently proven effective in reducing functional decline and disease progression in IPF. This is a major breakthrough for patients and physicians alike, but there is still a long way to go. In fact, neither pirfenidone nor nintedanib is a cure for IPF, and most patients continue to progress despite treatment. As such, comprehensive care of patients with IPF, including management of comorbidities/complications and physical debility and timely referral for palliative care or, in a small number of highly selected patients, lung transplantation, remains essential. Several agents with high pot...Continue Reading

References

Feb 1, 1989·The American Review of Respiratory Disease·A M CantinR G Crystal
Sep 1, 1994·American Journal of Respiratory and Critical Care Medicine·K IwaiY Hosoda
Jan 28, 1998·American Journal of Respiratory and Critical Care Medicine·J A BjorakerK P Offord
Oct 6, 2001·American Journal of Respiratory and Critical Care Medicine·T E KingR M Cherniack
Feb 28, 2002·The European Respiratory Journal·K R FlahertyF J Martinez
Aug 14, 2002·Mayo Clinic Proceedings·Marie-Christine AubryV Shane Pankratz
Aug 12, 2005·Current Opinion in Pulmonary Medicine·Craig E Daniels, James R Jett
Sep 2, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hiromi TomiokaHironobu Iwasaki
Jan 3, 2006·The European Respiratory Journal·G RaghuC A Pellegrini
Jul 1, 2006·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuGerry Oster
Mar 16, 2007·Chest·Harold R CollardDavid A Zisman
Sep 29, 2007·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingGanesh Raghu
Aug 8, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yuichi OzawaKingo Chida
Dec 10, 2009·The European Respiratory Journal·H TaniguchiUNKNOWN Pirfenidone Clinical Study Group in Japan
Dec 10, 2009·Thorax·J M HarrisP Cullinan
Jan 9, 2010·American Journal of Respiratory and Critical Care Medicine·Charlene D FellKevin R Flaherty
May 21, 2010·The New England Journal of Medicine·UNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research NetworkGary W Hunninghake
Oct 12, 2010·American Journal of Respiratory and Critical Care Medicine·Brett LeyTalmadge E King
Dec 7, 2010·American Journal of Respiratory and Critical Care Medicine·Roland M du BoisTalmadge E King
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
Apr 9, 2011·American Journal of Respiratory and Critical Care Medicine·Talmadge E KingJuergen Behr
May 17, 2011·Lancet·Paul W NobleUNKNOWN CAPACITY Study Group
Jun 28, 2011·American Journal of Respiratory and Critical Care Medicine·Joyce S LeeHarold R Collard
Jan 20, 2012·Respirology : Official Journal of the Asian Pacific Society of Respirology·Sakae HommaUNKNOWN Japan NAC Clinical Study Group
Mar 1, 2012·Clinics in Chest Medicine·Amy L Olson, Jeffrey J Swigris
Mar 1, 2012·Clinics in Chest Medicine·Charlene D Fell
May 9, 2012·American Journal of Respiratory and Critical Care Medicine·Imre NothUNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research Network (IPFnet)
May 23, 2012·The New England Journal of Medicine·UNKNOWN Idiopathic Pulmonary Fibrosis Clinical Research NetworkFernando J Martinez
Nov 29, 2012·Deutsche medizinische Wochenschrift·J BehrD Pittrow
May 18, 2013·The European Respiratory Journal·Ganesh RaghuUNKNOWN MUSIC Study Group
Dec 7, 2013·The European Respiratory Journal·Roland M du BoisTalmadge E King
Jan 17, 2014·The Lancet. Respiratory Medicine·Paolo SpagnoloVincent Cottin
Mar 5, 2014·European Respiratory Review : an Official Journal of the European Respiratory Society·Michael Kreuter
Mar 19, 2014·American Journal of Respiratory and Critical Care Medicine·Antonia MaraziotiGeorgios T Stathopoulos
Mar 19, 2014·American Journal of Respiratory and Critical Care Medicine·Kenneth S Knox
Mar 20, 2014·American Journal of Respiratory and Critical Care Medicine·Moisés Selman, Annie Pardo
May 13, 2014·The Lancet. Respiratory Medicine·Paolo SpagnoloRoland M du Bois
May 20, 2014·The New England Journal of Medicine·Fernando J MartinezGanesh Raghu
May 20, 2014·The New England Journal of Medicine·Luca RicheldiUNKNOWN INPULSIS Trial Investigators
May 20, 2014·The New England Journal of Medicine·Talmadge E KingUNKNOWN ASCEND Study Group

❮ Previous
Next ❯

Citations

Sep 28, 2016·PloS One·Adilson Santos Andrade-SousaRodolfo Paula Vieira
Sep 28, 2017·Expert Opinion on Investigational Drugs·Paolo ComeglioLinda Vignozzi
May 13, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xiaohong ZhengWen Ning
May 16, 2018·Respiration; International Review of Thoracic Diseases·Nicolas KahnMichael Kreuter
Feb 25, 2017·The European Respiratory Journal·Michael Kreuter, Vincent Cottin
Jun 18, 2017·Current Opinion in Pulmonary Medicine·Michael KreuterJürgen Behr
Sep 2, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Hangming DongShaoxi Cai
Mar 1, 2018·Respiration; International Review of Thoracic Diseases·Eva BrunnemerMichael Kreuter
Oct 25, 2020·Science Immunology·Patricia P OggerAdam J Byrne
Dec 3, 2020·International Journal of Molecular Sciences·Shu-Ching OuBing-Chang Chen
Apr 26, 2021·Archivos de bronconeumología·Guadalupe BermudoMaria Molina-Molina
Dec 29, 2020·Pharmacology & Therapeutics·Paolo SpagnoloChristopher J Ryerson
Mar 18, 2021·American Journal of Respiratory Cell and Molecular Biology·David C YangChing-Hsien Chen
Jul 30, 2021·Chinese Medicine·Yanfang PengYukun Xia
Aug 8, 2021·Journal of Clinical Medicine·Margherita SistoSabrina Lisi
Aug 28, 2021·International Journal of Molecular Sciences·Anna Valeria SamarelliEnrico Clini
Nov 23, 2021·JCI Insight·Marcy MartinJohn Y-J Shyy

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

ASCEND

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Therapeutics and Clinical Risk Management
Argyris TzouvelekisPaolo Spagnolo
Annals of Medicine
Paolo SpagnoloCarlo Vancheri
Respirology : Official Journal of the Asian Pacific Society of Respirology
Dominique ValeyreRoland du Bois
© 2022 Meta ULC. All rights reserved